Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study Takeshi Hatanaka , Satoru Kakizaki , Atsushi Hiraoka , Toshifumi Tada , Masashi Hirooka , Kazuya Kariyama , Joji Tani , Masanori Atsukawa , Koichi Takaguchi , Ei Itobayashi , Shinya Fukunishi , Kunihiko Tsuji , Toru Ishikawa , Kazuto Tajiri , Hironori Ochi , Satoshi Yasuda , Hidenori Toyoda , Chikara Ogawa , Takashi Nishimura , Noritomo Shimada , Kazuhito Kawata , Hisashi Kosaka , Takaaki Tanaka , Hideko Ohama , Kazuhiro Nouso , Asahiro Morishita , Akemi Tsutsui , Takuya Nagano , Norio Itokawa , Tomomi Okubo , Taeang Arai , Michitaka Imai , Atsushi Naganuma , Yohei Koizumi , Shinichiro Nakamura , Kouji Joko , Masaki Kaibori , Hiroko Iijima , Yoichi Hiasa , Takashi Kumada Cancer Medicine（2022）
Key words
etiology, immune checkpoint inhibitor, non-alcoholic steatohepatitis, propensity score matching, real-world data
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
